By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MedImmune, LLC 

319 North Bernardo Avenue

Mountain View  California  94043  U.S.A.
Phone: 650-919-6598 Fax: n/a


MedImmune is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland with facilities in Pennsylvania, California, Kentucky, the United Kingdom, and the Netherlands. UK facilities include vaccine manufacturing operations in Speke and antibody discovery and research laboratories in Cambridge.

With two marketed products and an advancing pipeline of promising candidates in the areas of infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience, MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees.

Last Updated: 07-10-2008

Key Statistics

Ownership: Subsidiary

Web Site: MedImmune, LLC
Employees: 2500




Company News
Micromet Buys Out MedImmune, LLC's Remaining Rights to Blinatumomab 11/5/2009 8:59:51 AM
Fourteen Abstracts Featuring MedImmune, Inc.'s Influenza and RSV Therapeutic Areas to Be Presented 4/29/2008 7:16:44 AM
Desperate But Not Crazy 4/1/2008 1:13:51 PM
MedImmune, Inc. Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis 11/26/2007 8:18:06 AM
AstraZeneca PLC (AZN) Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Group PLC  (CATG) Into MedImmune, Inc. 10/29/2007 7:35:03 AM
MedImmune, Inc. (MEDI) Founder, Wayne T. Hockmeyer, Ph.D., Retires 6/19/2007 1:34:28 PM
MedImmune, Inc. (MEDI) Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Convertible Senior Notes Due 2013 6/19/2007 10:15:40 AM
MedImmune, Inc. (MEDI) is Awarded Contract by U.S. Department of Health and Human Services to Retrofit Manufacturing Facilities for Production of Pandemic Influenza Vaccines 6/15/2007 12:44:48 PM
MedImmune, Inc. (MEDI) Wins Stevie(R) Award at 5th Annual American Business Awards(SM) 6/12/2007 1:13:01 PM
Infinity Pharmaceuticals, Inc. and MedImmune, Inc. (MEDI) Present Updated Phase I Results of IPI-504 in GIST at American Society of Clinical Oncology Annual Meeting 6/5/2007 1:31:09 PM